For a number of applications, gluten protein polymer structures are of the highest importance in determining end‐use properties. The present article focuses on gluten protein structures in the wheat grain, genotype‐ and environment‐related changes, protein structures in various applications, and their impact on quality. Protein structures in mature wheat grain or flour are strongly related to end‐use properties, although influenced by genetic and environment interactions. Nitrogen availability during wheat development and genetically determined plant development rhythm are the most important parameters determining the gluten protein polymer structure, although temperature during plant development interacts with the impact of the mentioned parameters. Glutenin subunits are the main proteins incorporated in the gluten protein polymer in extracted wheat flour. During dough mixing, gliadins are also incorporated through disulfide‐sulfhydryl exchange reactions. Gluten protein polymer size and complexity in the mature grain and changes during dough formation are important for breadmaking quality. When using the gluten proteins to produce plastics, additional proteins are incorporated in the polymer through disulfide‐sulfhydryl exchange, sulfhydryl oxidation, β‐eliminations with lanthionine formation, and isopeptide formation. In promising materials, the protein polymer structure is changed toward β‐sheet structures of both intermolecular and extended type and a hexagonal close‐packed structure is found. Increased understanding of gluten protein polymer structures is extremely important to improve functionality and end‐use quality of wheat‐ and gluten‐based products.
Intellectual disability (ID) is a clinically and genetically heterogeneous
disorder, affecting 1–3% of the general population. Although
research into the genetic causes of ID has recently gained momentum,
identification of pathogenic mutations that cause autosomal recessive ID (ARID)
has lagged behind, predominantly due to non-availability of sizeable families.
Here we present the results of exome sequencing in 121 large consanguineous
Pakistani ID families. In 60 families, we identified homozygous or compound
heterozygous DNA variants in a single gene, 30 affecting reported ID genes and
30 affecting novel candidate ID genes. Potential pathogenicity of these alleles
was supported by co-segregation with the phenotype, low frequency in control
populations and the application of stringent bioinformatics analyses. In another
eight families segregation of multiple pathogenic variants was observed,
affecting 19 genes that were either known or are novel candidates for ID.
Transcriptome profiles of normal human brain tissues showed that the novel
candidate ID genes formed a network significantly enriched for transcriptional
co-expression (P<0.0001) in the frontal cortex during fetal
development and in the temporal–parietal and sub-cortex during infancy
through adulthood. In addition, proteins encoded by 12 novel ID genes directly
interact with previously reported ID proteins in six known pathways essential
for cognitive function (P<0.0001). These results suggest that
disruptions of temporal parietal and sub-cortical neurogenesis during infancy
are critical to the pathophysiology of ID. These findings further expand the
existing repertoire of genes involved in ARID, and provide new insights into the
molecular mechanisms and the transcriptome map of ID.
Films thermoformed from commercial potato protein concentrate exhibited a constant Young's modulus and increasing strain at break with increasing processing temperature, in contrast to the usually observed behaviour for protein-based materials.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.